Palmitoleate induces hepatic steatosis but suppresses liver inflammatory response in mice

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Guo, Xin ^a   Li, Honggui ^a   Xu, Hang ^a   Halim, Vera ^a   Zhang, Weiyu ^b   Wang, Huan ^b   Ong, Kuok Teong ^b   Woo, Shih Lung ^a   Walzem, Rosemary L ^a   Mashek, Douglas G ^b   Dong, Hui ^c   Lu, Fuer ^c   Wei, Lai ^d   Huo, Yuqing ^e   Wu, Chaodong ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^e MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID SYNTHASE; INSULIN; INTERLEUKIN 6; PALMITOLEIC ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; FATTY LIVER; HEPATITIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; KUPFFER CELL; LIPID STORAGE; LIVER CELL; MACROPHAGE; MALE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; DIET, FAT-RESTRICTED; DIETARY SUPPLEMENTS; FATTY ACID SYNTHETASE COMPLEX; FATTY ACIDS, MONOUNSATURATED; FATTY LIVER; HEPATOCYTES; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

MUS;

EID: 84863086400     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039286     Document Type: Article

References (38)

1. Sanyal AJ, (2005) Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2, 46-53.
2. Tilg H, Moschen AR, (2010) Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis. Hepatology 52, 1836-1846.
3. Tilg H, Kaser A, (2005) Treatment strategies in nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2, 148-155.
4. Marchesini G, Bianchi G, Tomassetti S, Zoli M, Melchionda N, (2001) Metformin in non-alcoholic steatohepatitis. Lancet 358, 893-894.
5. Angulo P, (2006) NAFLD, Obesity, and Bariatric Surgery. Gastroenterology 130, 1848-1852.
6. Farrell GC, Larter CZ, (2006) Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology 43, S99-S112.
7. Neuschwander-Tetri BA, (2010) NASH: Thiazolidinediones for NASH-one pill doesn't fix everything. Nat Rev Gastroenterol Hepatol 7, 243-244.
8. Shimomura I, Bashmakov Y, Horton JD, (1999) Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274, 30028-30032.
9. Browning JD, Horton JD, (2004) Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114, 147-152.
10. Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, Vats D, Morel CR, et al. (2008) Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance. Cell Metabolism 7, 496-507.
11. Joshi-Barve S, Barve SS, Amancherla K, Gobejishvili L, Hill D, et al. (2007) Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 46, 823-830.
12. Nakamura S, Takamura T, Matsuzawa-Nagata N, Takayama H, Misu H, et al. (2009) Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. J Biol Chem 284, 14809-14818.
13. Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, et al. (2004) Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279, 32345-32353.
14. Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, et al. (2008) Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 134, 933-944.
15. Yang ZH, Miyahara H, Hatanaka A, (2011) Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes. Lipids Health Dis 10, 120.
16. Petit JM, Guiu B, Duvillard L, Jooste V, Brindisi MC, et al. (2012) Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes. Clin Nutr [Epub ahead of print].
17. Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, et al. (2010) Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes. Am J Clin Nutr 92, 1350-1358.
18. Gong J, Campos H, McGarvey S, Wu Z, Goldberg R, et al. (2011) Adipose tissue palmitoleic acid and obesity in humans: does it behave as a lipokine? Am J Clin Nutr 93, 186-191.
19. Akazawa Y, Cazanave S, Mott JL, Elmi N, Bronk SF, et al. (2010) Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis. J Hepatol 52, 586-593.
20. Puri P, Wiest MM, Cheung O, Mirshahi F, Sargeant C, et al. (2009) The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 50, 1827-1838.
21. Liu X, Miyazaki M, Flowers MT, Sampath H, Zhao M, et al. (2010) Loss of stearoyl-CoA desaturase-1 attenuates adipocyte inflammation: effects of adipocyte-derived oleate. Arterioscler Thromb Vasc Biol 30, 31-38.
22. Dentin R, Benhamed F, Pégorier JP, Foufelle F, Viollet B, et al. (2005) Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation. J Clin Invest 115, 2843-2854.
23. Tauriainen E, Luostarinen M, Martonen E, Finckenberg P, Kovalainen M, et al. (2011) Distinct effects of calorie restriction and resveratrol on diet-induced obesity and fatty liver formation. J Nutr Metab 2011, 525094.
24. Kelley DE, McKolanis TM, Hegazi RAF, Kuller LH, Kalhan SC, (2003) Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 285, E906-916.
25. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, et al. (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat Med 11, 183-190.
26. Huo Y, Guo X, Li H, Wang H, Zhang W, et al. (2010) Disruption of inducible 6-phosphofructo-2-kinase ameliorates diet-induced adiposity but exacerbates systemic insulin resistance and adipose tissue inflammatory response. J Biol Chem 285, 3713-3721.
27. Huo Y, Guo X, Li H, Xu H, Halim V, et al. (2012) Targeted overexpression of inducible 6-phosphofructo-2-kinase in adipose tissue increases fat deposition but protects against diet-induced insulin resistance and inflammatory responses. J Biol Chem, Epub ahead of print.
28. Lonardo A, Lombardini S, Scaglioni F, Carulli L, Ricchi M, et al. (2006) Hepatic steatosis and insulin resistance: Does etiology make a difference? J Hepatol 44, 190-196.
29. Wendel AA, Purushotham A, Liu LF, Belury MA, (2008) Conjugated linoleic acid fails to worsen insulin resistance but induces hepatic steatosis in the presence of leptin in ob/ob mice. J Lipid Res 49, 98-106.
30. Zhang J, Fu M, Cui T, Xiong C, Xu K, et al. (2004) Selective disruption of PPARγ2 impairs the development of adipose tissue and insulin sensitivity. Proc Natl Acad Sci USA 101, 10703-10708.
31. Monetti M, Levin MC, Watt MJ, Sajan MP, Marmor S, et al. (2007) Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab 6, 69-78.
32. Deng Z, Liu Y, Cunren Liu C, Xiang X, Wang J, et al. (2009) Immature myeloid cells induced by a high-fat diet contribute to liver inflammation. Hepatology 50, 1412-1420.
33. Wu C, Okar DA, Newgard CB, Lange AJ, (2001) Overexpression of 6-phosphofructo-2- kinase/fructose-2,6-bisphosphatase in mouse liver lowers blood glucose by suppression of hepatic glucose production. J Clin Invest 107, 91-98.
34. Wu C, Kang JE, Peng L, Li H, Khan SA, et al. (2005) Enhancing hepatic glycolysis reduces obesity: Differential effects on lipogenesis depend on site of glycolytic modulation. Cell Metabolism 2, 131-140.
35. Wu C, Khan SA, Peng LJ, Li H, Camela S, et al. (2006) Perturbation of glucose flux in the liver by decreasing fructose-2,6-bisphosphate levels causes hepatic insulin resistance and hyperglycemia. Am J Physiol Endocrinol Metab 291, E536-543.
36. Guo X, Xu K, Zhang J, Li H, Zhang W, et al. (2010) Involvement of inducible 6-phosphofructo-2-kinase in the anti-diabetic effect of PPARγ activation in mice. J Biol Chem 285, 23711-23720.
37. Bu SY, Mashek MT, Mashek DG, (2009) Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity. J Biol Chem 284, 30474-30483.
38. Sekiya M, Yahagi N, Matsuzaka T, Takeuchi Y, Nakagawa Y, et al. (2007) SREBP-1-independent regulation of lipogenic gene expression in adipocytes. J Lipid Res 48, 1581-1591.